期刊简介

  《特别健康》杂志原由省卫生厅主管,已创办20多年,曾创下单期发行近20万份的辉煌。本刊主要介绍世界医学前沿进展状况,报道我国医学院校、科研院所最新的研究成果,介绍医学新理论,总结临床经验,推动我国医学事业的发展,为人类健康服务。

  《特别健康》本刊以广大医护工作人员为读者群,用医学的科学理论和临床技术指导医务工作者的医疗服务实践,为广大医务工作者提供良好的教育机会和学术交流的平台,致力于全面提高医师的综合素质。


首页>特别健康杂志
  • 杂志名称:特别健康杂志
  • 主管单位:湖北日报传媒集团
  • 主办单位:湖北特别关注传媒股份有限公司
  • 国际刊号:2095-6851
  • 国内刊号:42-1852/R
  • 出版周期:月刊
期刊荣誉:中国核心期刊遴选数据库期刊收录:国家图书馆馆藏, 万方收录(中), 维普收录(中), 上海图书馆馆藏
特别健康杂志2017年第19期

A REVIEW ON CANCER IMMUNOTHERAPY VIA DENDRITIC CELLS

ALANAZI MANSOUR RASHED M;ALOTAIBI ABDULLAH SAUD M;AHMAD MEESAQ

关键词:Immunotherapy, Dendritic Cells, Cancer Vaccines
摘要:Cancer is considered as a devastating disease and a leading cause of deaths around the world.According to WHO,1.4 million cancer cases are seen in 2012.Cancer is usually asymptomatic at its initial stages,but it shows very pathetic signs and symptoms at advanced stages.There are various ways to diagnose cancer as taking images of body parts,some blood tests and histological study of body cells.The advanced malagnancies are not sensitive to therapies including surgery,chemotherapy and radiotherapy,and also accompanied by adverse effects,and also do not give the promising results.These adverse effects are usually toxic.Recent studies in immune therapy has shown non-toxdc and effective results given by dendritic cells(DCs).DCs are the potent antigen presenting cells and bave ability to stimulate strong immune response in the body by activating T cells.DCs can be prepared in vitro,can be combined with cytokines,peptides and different molecules to develop cancer vaccines.These cancer vaccines offer low toxicity and have ability to induce anticancer immune response.Under the banner of immunotherapy,the aim of these vaccines is to increase body's immune response against cancers.This article reviews the basic biology of dendritic cells,and future direction of DCs based cancer vaccines.